{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:24:02Z","timestamp":1784305442825,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:italic>Leishmania infantum<\/jats:italic> is an intracellular protozoan parasite which is endemic in countries of the Mediterranean Basin. Leishmaniosis is increasingly diagnosed in non-endemic areas due to the relocation of dogs from endemic areas and the travel of dogs to and from these areas. The prognosis of leishmaniosis in these dogs may differ from that of those in endemic areas. The aims of this study were (1) to determine the Kaplan\u2013Meier estimated survival time for dogs with leishmaniosis in the Netherlands (a non-endemic country), (2) to determine if clinicopathological variables at the time of diagnosis predicted the survival of these dogs, and (3) to evaluate the effect of a two-phase therapy protocol of allopurinol monotherapy followed by meglumine antimoniate and\/or miltefosine in the case of incomplete remission or relapse.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The database of the Department of Clinical Sciences of Companion Animals of the Faculty of Veterinary Medicine, Utrecht University was investigated for leishmaniosis patients. Patient records were reviewed for signalment and clinicopathological data at the time of diagnosis. Only treatment-naive patients were included. Follow-up was performed during the study by phone contact and included treatment received and date and cause of death. Univariate analysis was performed using the Cox proportional hazards regression model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The estimated median Kaplan\u2013Meier survival time was 6.4\u00a0years. In the univariate analysis, increases in monocyte, plasma urea and creatinine concentrations, and urine protein to creatinine ratio were all significantly associated with decreased survival time. The majority of patients only received allopurinol monotherapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Canine leishmaniosis patients in our study population in the Netherlands, which is  non-endemic for the disease, had an estimated Kaplan\u2013Meier median survival time of 6.4\u00a0years, which is comparable to the outcome of other reported therapy protocols. Increased plasma urea and creatinine concentrations and monocyte concentration were statistically associated with an increased risk of death. We conclude that initial allopurinol monotherapy for 3 months should be effective in more than half of canine leishmaniosis cases, provided there is adequate follow-up, and that meglumine antimoniate or miltefosine therapy should be started as the second phase of the protocol in cases where remission is  incomplete or there is a relapse.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13071-023-05777-2","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T14:35:24Z","timestamp":1684161324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy"],"prefix":"10.1186","volume":"16","author":[{"given":"Marja Klazina","family":"de Jong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aukje","family":"Rappoldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke","family":"Broere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine Jantine","family":"Piek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,15]]},"reference":[{"key":"5777_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1756-3305-4-86","volume":"4","author":"L Solano-Gallego","year":"2011","unstructured":"Solano-Gallego L, Mir\u00f3 G, Koutinas A, Cardoso L, Pennisi MG, Ferrer L, et al. LeishVet guidelines for the practical management of canine leishmaniosis. Parasit Vectors. 2011;4:86. https:\/\/doi.org\/10.1186\/1756-3305-4-86.","journal-title":"Parasit Vectors."},{"key":"5777_CR2","unstructured":"Slappendel RJ, Teske E. A review of canine leishmaniasis presenting outside endemic areas."},{"key":"5777_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1751-0147-43-195","volume":"43","author":"E Teske","year":"2002","unstructured":"Teske E, van Knapen F, Beijer EG, Slappendel RJ. Risk of infection with Leishmania spp. in the canine population in the Netherlands. Acta Vet Scand. 2002;43:195\u2013201.","journal-title":"Acta Vet Scand"},{"key":"5777_CR4","unstructured":"Radstake C. Immigratie van buitenlandse (zwerf) honden en katten naar Nederland de cijfers 2016. 2017. https:\/\/www.stray-afp.org\/nl\/wp-content\/uploads\/sites\/2\/2017\/11\/immigratie-van-buitenlandse-zwerf-honden-en-katten-naar-Nederland-de-cijfers-2016.pdf. Accessed 27 July 2018."},{"key":"5777_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01652176.1988.9694140","volume":"10","author":"RJ Slappendel","year":"1988","unstructured":"Slappendel RJ. Canine leishmaniasis. A review based on 95 cases in the Netherlands. Vet Q. 1988;10:1\u201316. https:\/\/doi.org\/10.1080\/01652176.1988.9694140.","journal-title":"Vet Q"},{"key":"5777_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.vetpar.2009.03.025","volume":"163","author":"SE Shaw","year":"2009","unstructured":"Shaw SE, Langton DA, Hillman TJ. Canine leishmaniosis in the United Kingdom: a zoonotic disease waiting for a vector? Vet Parasitol. 2009;163:281\u20135. https:\/\/doi.org\/10.1016\/j.vetpar.2009.03.025.","journal-title":"Vet Parasitol"},{"key":"5777_CR7","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.2460\/javma.236.11.1184","volume":"236","author":"S Paltrinieri","year":"2010","unstructured":"Paltrinieri S, Solano-Gallego L, Fondati A, Lubas G, Gradoni L, Castagnaro M, et al. Guidelines for diagnosis and clinical classification of leishmaniasis in dogs. J Am Vet Med Assoc. 2010;236:1184\u201391. https:\/\/doi.org\/10.2460\/javma.236.11.1184.","journal-title":"J Am Vet Med Assoc"},{"key":"5777_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.tvjl.2013.04.001","volume":"198","author":"X Roura","year":"2013","unstructured":"Roura X, Fondati A, Lubas G, Gradoni L, Maroli M, Oliva G, et al. Prognosis and monitoring of leishmaniasis in dogs: a working group report. Vet J. 2013;198:43\u20137. https:\/\/doi.org\/10.1016\/j.tvjl.2013.04.001.","journal-title":"Vet J"},{"key":"5777_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-3164.2005.00460.x","volume":"16","author":"C Noli","year":"2005","unstructured":"Noli C, Auxilia ST. Treatment of canine Old World visceral leishmaniasis: a systematic review. Vet Dermatol. 2005;16:213\u201332 (VDE460[pii]).","journal-title":"Vet Dermatol"},{"key":"5777_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/01652176.1997.9694729","volume":"19","author":"RJ Slappendel","year":"1997","unstructured":"Slappendel RJ, Teske E. The effect of intravenous or subcutaneous administration of meglumine antimonate (Glucantime) in dogs with leishmaniasis. A randomized clinical trial. Vet Q. 1997;19:10\u20133. https:\/\/doi.org\/10.1080\/01652176.1997.9694729.","journal-title":"Vet Q"},{"key":"5777_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1136\/vr.100637","volume":"171","author":"K Geisweid","year":"2012","unstructured":"Geisweid K, Mueller R, Sauter-Louis C, Hartmann K. Prognostic analytes in dogs with Leishmania infantum infection living in a non-endemic area. Vet Rec. 2012;171:399. https:\/\/doi.org\/10.1136\/vr.100637.","journal-title":"Vet Rec"},{"key":"5777_CR12","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1128\/jcm.27.10.2252-2257.1989","volume":"27","author":"A el Harith","year":"1989","unstructured":"el Harith A, Slappendel RJ, Reiter I, van Knapen F, de Korte P, Huigen E, et al. Application of a direct agglutination test for detection of specific anti-Leishmania antibodies in the canine reservoir. J Clin Microbiol. 1989;27:2252\u20137.","journal-title":"J Clin Microbiol"},{"key":"5777_CR13","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0034-5288(18)32573-6","volume":"30","author":"WE van den Brom","year":"1981","unstructured":"van den Brom WE, Biewenga WJ. Assessment of glomerular filtration rate in normal dogs: analysis of the 51Cr-EDTA clearance and its relation to several endogenous parameters of glomerular filtration. Res Vet Sci. 1981;30:152\u20137.","journal-title":"Res Vet Sci"},{"key":"5777_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/vetsci7030128","volume":"7","author":"M Pereira","year":"2020","unstructured":"Pereira M, Santos R, Oliveira R, Costa L, Prata A, Gon\u00e7alves V, et al. Prognostic factors and life expectancy in canine leishmaniosis. Vet Sci. 2020;7:128. https:\/\/doi.org\/10.3390\/vetsci7030128.","journal-title":"Vet Sci"},{"key":"5777_CR15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.tvjl.2010.05.025","volume":"188","author":"M Torres","year":"2011","unstructured":"Torres M, Bardag\u00ed M, Roura X, Zanna G, Ravera I, Ferrer L. Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol. Vet J. 2011;188:346\u201351. https:\/\/doi.org\/10.1016\/j.tvjl.2010.05.025.","journal-title":"Vet J"},{"key":"5777_CR16","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1354\/vp.40-6-677","volume":"40","author":"FAL Costa","year":"2003","unstructured":"Costa FAL, Goto H, Saldanha LCB, Silva SMMS, Sinhorini IL, Silva TC, et al. Histopathologic patterns of nephropathy in naturally acquired canine visceral leishmaniasis. Vet Pathol. 2003;40:677\u201384. https:\/\/doi.org\/10.1354\/vp.40-6-677.","journal-title":"Vet Pathol"},{"key":"5777_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1939-1676.2006.tb02850.x","volume":"20","author":"K Plevraki","year":"2006","unstructured":"Plevraki K, Koutinas AF, Kaldrymidou H, Roumpies N, Papazoglou LG, Saridomichelakis MN, et al. Effects of allopurinol treatment on the progression of chronic nephritis in canine leishmaniosis (Leishmania infantum). J Vet Intern Med. 2006;20:228\u201333.","journal-title":"J Vet Intern Med"},{"key":"5777_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.rvsc.2019.08.026","volume":"126","author":"MA Daza Gonzalez","year":"2019","unstructured":"Daza Gonzalez MA, Miro G, Fermin Rodriguez M, RuperezNoguer C, Fragio AC. Short-term impacts of meglumine antimoniate treatment on kidney function in dogs with clinical leishmaniosis. Res Vet Sci. 2019;126:131\u20138. https:\/\/doi.org\/10.1016\/j.rvsc.2019.08.026.","journal-title":"Res Vet Sci"},{"key":"5777_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.rvsc.2006.10.008","volume":"83","author":"FA Ikeda-Garcia","year":"2007","unstructured":"Ikeda-Garcia FA, Lopes RS, Ciarlini PC, Marques FJ, Lima VMF, Perri SHV, et al. Evaluation of renal and hepatic functions in dogs naturally infected by visceral leishmaniasis submitted to treatment with meglumine antimoniate. Res Vet Sci. 2007;83:105\u20138. https:\/\/doi.org\/10.1016\/j.rvsc.2006.10.008.","journal-title":"Res Vet Sci"},{"key":"5777_CR20","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1177\/0192623309344088","volume":"37","author":"P Bianciardi","year":"2009","unstructured":"Bianciardi P, Brovida C, Valente M, Aresu L, Cavicchioli L, Vischer C, et al. Administration of miltefosine and meglumine antimoniate in healthy dogs: clinicopathological evaluation of the impact on the kidneys. Toxicol Pathol. 2009;37:770\u20135. https:\/\/doi.org\/10.1177\/0192623309344088.","journal-title":"Toxicol Pathol"},{"key":"5777_CR21","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.vetpar.2014.08.022","volume":"205","author":"GG de Almeida Leal","year":"2014","unstructured":"de Almeida Leal GG, Roatt BM, de Oliveira Aguiar-Soares RD, Carneiro CM, Giunchetti RC, Teixeira-Carvalho A, et al. Immunological profile of resistance and susceptibility in naturally infected dogs by  Leishmania infantum. Vet Parasitol. 2014;205:472\u201382. https:\/\/doi.org\/10.1016\/j.vetpar.2014.08.022.","journal-title":"Vet Parasitol"},{"key":"5777_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.vetimm.2008.10.307","volume":"128","author":"AB Reis","year":"2009","unstructured":"Reis AB, Martins-Filho OA, Teixeira-Carvalho A, Giunchetti RC, Carneiro CM, Mayrink W, et al. Systemic and compartmentalized immune response in canine visceral leishmaniasis. Vet Immunol Immunopathol. 2009;128:87\u201395. https:\/\/doi.org\/10.1016\/j.vetimm.2008.10.307.","journal-title":"Vet Immunol Immunopathol"},{"key":"5777_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0304-4017(01)00399-5","volume":"98","author":"AF Koutinas","year":"2001","unstructured":"Koutinas AF, Saridomichelakis MN, Mylonakis ME, Leontides L, Polizopoulou Z, Billinis C, et al. A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis. Vet Parasitol. 2001;98:247\u201361. https:\/\/doi.org\/10.1016\/S0304-4017(01)00399-5.","journal-title":"Vet Parasitol"},{"key":"5777_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11259-007-0060-1","volume":"31","author":"M Sasanelli","year":"2007","unstructured":"Sasanelli M, Paradies P, de Caprariis D, Greco B, De Palo P, Palmisano D, et al. Acute-phase proteins in dogs naturally infected with Leishmania infantum during and after long-term therapy with allopurinol. Vet Res Commun. 2007;31:335\u20138. https:\/\/doi.org\/10.1007\/s11259-007-0060-1.","journal-title":"Vet Res Commun"},{"key":"5777_CR25","doi-asserted-by":"publisher","first-page":"100048","DOI":"10.1016\/j.jvacx.2019.100048","volume":"4","author":"LFM Nascimento","year":"2020","unstructured":"Nascimento LFM, Miranda DFH, Moura LD, Pinho FA, Werneck GL, Khouri R, et al. Allopurinol therapy provides long-term clinical improvement, but additional immunotherapy is required for sustained parasite clearance, in L. infantum-infected dogs. Vaccine. 2020;4:100048. https:\/\/doi.org\/10.1016\/j.jvacx.2019.100048.","journal-title":"Vaccine"},{"key":"5777_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1756-3305-7-110","volume":"7","author":"P Bourdeau","year":"2014","unstructured":"Bourdeau P, Saridomichelakis MN, Oliveira A, Oliva G, Kotnik T, G\u00e1lvez R, et al. Management of canine leishmaniosis in endemic SW European regions: a questionnaire-based multinational survey. Parasit Vectors. 2014;7:110. https:\/\/doi.org\/10.1186\/1756-3305-7-110.","journal-title":"Parasit Vectors."},{"key":"5777_CR27","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3390\/ani12060731","volume":"12","author":"MA Pereira","year":"2022","unstructured":"Pereira MA, Santos R, N\u00f3brega C, Mega C, Cruz R, Esteves F, et al. A questionnaire-based survey on the long-term management of canine leishmaniosis by veterinary practitioners. Animals (Basel). 2022;12:731. https:\/\/doi.org\/10.3390\/ani12060731.","journal-title":"Animals (Basel)."},{"key":"5777_CR28","doi-asserted-by":"publisher","DOI":"10.2460\/javma.236.11.1192","author":"G Oliva","year":"2010","unstructured":"Oliva G, Roura X, Crotti A, Maroli M, Castagnaro M, Gradoni L, et al. Guidelines for treatment of leishmaniasis in dogs. J Am Vet Med Assoc. 2010. https:\/\/doi.org\/10.2460\/javma.236.11.1192.","journal-title":"J Am Vet Med Assoc"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-023-05777-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-023-05777-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-023-05777-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T14:40:18Z","timestamp":1684161618000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-023-05777-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5777"],"URL":"https:\/\/doi.org\/10.1186\/s13071-023-05777-2","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,15]]},"assertion":[{"value":"23 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"163"}}